Ganitumab - CAS 905703-97-1

Ganitumab (AMG 479) is a highly potent monoclonal antibody targeting the type 1 insulin-like growth factor receptor (IGF1R) . Recognized for binding IGF1R at low concentrations with a KD value of 0.22 nM, Ganitumab inhibits IGF1R interactions with IGF1 and IGF2 in mice, making it useful for cancer research.

IGF-1R

Tyrosine Kinase/Adaptors

905605

1

-20°C

Ice Packs

Inhibitory Antibodies